For example, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is a regulatory enzyme involved in liver cholesterol biosynthesis, which is the target enzyme of anti-hyperlipidemia drugs [132,133]. Here, HMGCR is linked to hyperlipidemia.